ASMB stock

Assembly Biosciences Inc (ASMB) financials · rev $72.3M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Assembly Biosciences Inc (ASMB) rev $72.3M.

Cached annual income statement
LineFY2025FY2024
Revenue$72.3M$28.5M
Operating Income-$12.1M-$45.4M
Net Income-$6.12M-$40.2M
EPS (Diluted)-$0.55-$6.69
Cached annual balance sheet
LineFY2025FY2024
Total Assets$257.6M$119.2M
Current Assets$254.5M$115.5M
Cash & Equivalents$58.5M$38.3M
PP&E$221.0K$284.0K
Total Liabilities$50.8M$85.8M
Current Liabilities$48.8M$47.8M
Shareholders' Equity$206.8M$33.4M
Retained Earnings-$832.0M-$825.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$41.1M-$51.1M
CapEx$66.0K$28.0K
Investing Cash Flow-$113.5M$40.2M
Financing Cash Flow$174.7M$29.4M
Net Change in Cash$20.1M$18.5M
Free Cash Flow-$41.2M-$51.1M
These statements as JSON? API free 100/day

FAQ

What is ASMB P/E and revenue?

Assembly Biosciences Inc (ASMB) rev $72.3M.

What is ASMB revenue?

Assembly Biosciences Inc last cached revenue is $72.3M (FY2025).

Is ASMB profitable?

Assembly Biosciences Inc last cached net income is -$6.12M (FY2025).

What are ASMB total assets?

Assembly Biosciences Inc last cached total assets are $257.6M (FY2025).

What is ASMB free cash flow?

Assembly Biosciences Inc last cached free cash flow is -$41.2M (FY2025).

Not investment advice. Cached statements, not a live tape.